Medix (331A) · RiskRestated
Intensifying competition from competitors and new entrants
First written in FY2025. 1 of 2 entries say "Restated". Latest entry: FY2026.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Intensifying competition from competitors and new entrantsA theme 604 companies write about · 629 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2026: 29 of 92 companies on the "Worse" side.
124 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.Comparing 200 of the theme's 629 threads.Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「If competitors develop innovative technologies in the future or competition intensifies because of new market entrants, this could have a material impact on our group’s business activities, financial condition and operating results.」
The company continues to identify competitors’ technological development and intensified competition from new market entrants as risks. - FY2025First statedAnnual report
「If competitors develop innovative technologies in the future or competition intensifies because of new market entrants, this could have a material impact on our business activities, financial condition and operating results.」
The company identifies competitors’ technological development and intensified competition from new market entrants as risks.